bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.08.30.610465

Immunophenotyping of T cells combined with Vβ antibodies identifies long lasting CMV related T cell expansions with a consistent TIGIT and PD-1 phenotype

Abstract

Simultaneous analysis of T cell receptor repertoire and T cell phenotype is of high relevance to gain a deeper understanding on the T cell response in terms of differentiation, kinetics and persistence. Also it is currently unknown how the repertoire of immune checkpoints on T cells evolves over time. To fully capture the heterogenous response, TCR repertoire and T cell phenotype analysis is preferably performed at the single-cell level, but this is costly and analytically challenging. Therefore, we developed a flow cytometry based method that allows for simultaneous characterization of the T cell TCR V{beta} and the phenotype. We generated a 9-tube 24-color panel with antibodies against maturation and activation markers, and 24 TCR V{beta} chains. Peripheral blood mononuclear cells from 5 healthy controls were analyzed, revealing the presence of oligoclonal expansions. Within the CD27+CD28+ memory T cell population, oligoclonal expansions were characterized by a T regulatory, or KLRG1+CCR7-CD27low phenotype. Within the late CD27- and/or CD28-memory T cells, the populations with the lowest TCR V{beta} diversity expressed CX3CR1. As a proof of principle, we demonstrate the dynamics of circulating oligoclonal T cell expansions that emerged following hematopoietic stem cell transplantation in the presence of CMV in 2 patients. We provide evidence that oligoclonal T cells transferred from donor to recipient can be traced up to at least 2.5 years while maintaining its phenotype. Mostly TIGIT and PD-1 were critical in defining T cell expansions, while CD45RA, CD57, CD56 and NKG2A were variably expressed. Overall, we developed a phenotype based method to trace T cell populations, that is widely applicable to different settings in which the T cell response needs to be monitored.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

van Ostaijen-ten Dam, M. M., Schilham, M. W., Lankester, A. C., Melsen, J. E.. 2024-08-30. Immunophenotyping of T cells combined with Vβ antibodies identifies long lasting CMV related T cell expansions with a consistent TIGIT and PD-1 phenotype. https://doi.org/10.1101/2024.08.30.610465

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ksp37 is a rapidly mobilized NK cell secretory protein that engages FGF2

A key feature of natural killer (NK) cells is their preloaded arsenal of effector molecules, allowing them to rapidly respond upon activation. In this study, we characterized a previously unexplored secretory protein, termed killer-specific secretory protein of 37 kDa (Ksp37), which is highly abundant in differentiated CD56dim NK cells. Ksp37 is rapidly secreted in a dose-dependent and JAK-1 dependent manner upon low levels of cytokine stimulation, making it a sensitive readout for NK cell activation. Following secretion, intracellular levels were rapidly replenished, preserving responsiveness to subsequent cytokine stimulation. We found that Ksp37 is stored in polarized intracellular compartments distinct from those containing canonical cytotoxic effector molecules, including granzyme B and perforin, which require stronger stimulation for release. Lastly, we identified Ksp37 as a novel binding partner of fibroblast growth factor 2 (FGF2). This opens new avenues of exploration for the role of NK cells in remodeling their extracellular environment by modulating the FGF2-FGFR1 axis, which plays a key role in tumor growth, angiogenesis and tissue repair.

immunology↗

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗